Stray Dog

HIMS launches Labs AI, its first AI care agent

  • Good news: On 7 May HIMS launched Labs AI, which interprets 130 biomarkers across 10 health areas and spots patterns between them.
  • Good news: It should make Labs subscriptions stickier and feeds the data flywheel; it does not diagnose.
Read the full notes

On 7 May HIMS launched Labs AI, an AI agent embedded in the platform that helps users interpret their laboratory test results. Core capabilities: interpretation of 130 biomarkers (across 10 health areas), personalised health profiles, pattern recognition across markers and interactive Q&A.

Read more

It is positioned as an education and analysis tool, does not diagnose and proactively suggests that users contact a clinician when necessary. What it means for the business model: stickier Labs subscriptions, the starting point of an AI platform strategy, a lighter load on clinicians, a data flywheel effect and a moat unique to the platform. It fits HIMS's broader shift from selling drugs online to a personalised health platform. More AI agents will follow.